H. Kalofonos

发表

Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.

U. Dafni, G. Aravantinos, G. Fountzilas, 2009, Anticancer research.

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.

U. Dafni, H. Gogas, C. Markopoulos, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Scintigraphic Imaging of Sarcomatous Tumors with [111In-DTPA-Phe-1]-Octreotide

C. Kalogeropoulou, D. Apostolopoulos, P. Vassilakos, 2000, Oncology.

Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study

M. Dimopoulos, N. Pavlidis, G. Fountzilas, 2008, Cancer Chemotherapy and Pharmacology.

Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).

M. Dimopoulos, N. Pavlidis, T. Economopoulos, 2009, Anticancer research.

Preliminary results of the use of Re-186-HEDP for palliation of pain in patients with metastatic bone disease.

C. Kosmas, D. Apostolopoulos, P. Vassilakos, 2000, American journal of clinical oncology.

Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.

J. Taylor‐Papadimitriou, J. Waxman, S. Pervez, 1989, British Journal of Cancer.

High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.

C. Wilson, S. Stewart, D. Snook, 1988, In vivo.

Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.

N. Pavlidis, K. Syrigos, G. Fountzilas, 2006, Anticancer research.

Dose-Dense Sequentials Chemotherapy with Epirubicin and Paclitaxel in Advanced Breast Cancer

N. Pavlidis, C. Papadimitriou, C. Papadimitriou, 2001, Cancer investigation.

A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.

U. Dafni, N. Pavlidis, G. Aravantinos, 2007, Anticancer research.

Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)

T. Postma, A. Schenone, C. Briani, 2013 .

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.

M. Dimopoulos, K. Syrigos, T. Economopoulos, 2007, Lung cancer.

Docetaxel and Gemcitabine in Anthracycline-Resistant Advanced Breast Cancer: A Hellenic Cooperative Oncology Group Phase II Study

N. Pavlidis, G. Aravantinos, G. Fountzilas, 2000, Cancer investigation.

A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.

N. Pavlidis, G. Fountzilas, C. Bamia, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.

M. Dimopoulos, U. Dafni, N. Pavlidis, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-Dense Sequential Adjuvant Chemotherapy with Epirubicin, Paclitaxel and CMF in High-Risk Breast Cancer

N. Pavlidis, G. Aravantinos, C. Papadimitriou, 2001, Oncology.

EGFR, HER‐2 and COX‐2 levels in colorectal cancer

A. Papavassiliou, A. Antonacopoulou, C. Scopa, 2008, Histopathology.

Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.

U. Dafni, T. Economopoulos, K. Syrigos, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.

N. Pavlidis, C. Papadimitriou, G. Fountzilas, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.

M. Dimopoulos, G. Fountzilas, P. Papakostas, 1998, Oncology.

OBSTRUCTIVE JAUNDICE DUE TO INTRACHOLEDOCHAL BLOOD CLOT: AN UNUSUAL EARLY PRESENTATION OF PRIMARY HEPATIC CARCINOMA

C. Vagianos, J. Androulakis, D. Karavias, 1993, The British journal of clinical practice.

Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes: Five-Year Results of the Hellenic Cooperative Oncology Group Randomized HE 10/92 Study

K. Kyriakou, A. Adamou, N. Pavlidis, 2004, American journal of clinical oncology.

Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas.

P Ravazoula, P. Ravazoula, G. Kourounis, 2006, European journal of gynaecological oncology.

Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.

M. Dimopoulos, N. Pavlidis, H. Gogas, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival

M. Dimopoulos, N. Pavlidis, H. Gogas, 2006, Breast Cancer Research and Treatment.